Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.81% | 29.00% | 26.55% | 10.33% | 0.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.81% | 29.00% | 26.55% | 10.33% | 0.52% |
| Cost of Revenue | 21.33% | 25.65% | 22.92% | 8.53% | 1.72% |
| Gross Profit | 25.10% | 34.46% | 32.36% | 13.25% | -1.30% |
| SG&A Expenses | 25.40% | 26.02% | 30.03% | 18.46% | 4.95% |
| Depreciation & Amortization | 30.73% | 59.64% | 50.40% | 30.94% | -21.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.96% | 26.58% | 25.94% | 12.42% | 2.09% |
| Operating Income | 18.40% | 101.15% | 41.46% | -59.72% | -30.42% |
| Income Before Tax | -105.91% | 496.55% | -281.58% | -113.65% | 189.29% |
| Income Tax Expenses | -105.24% | 168.28% | -203.17% | -97.94% | 176.06% |
| Earnings from Continuing Operations | -106.06% | 305.00% | -313.22% | -116.55% | 192.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.06% | 305.00% | -313.22% | -116.55% | 192.84% |
| EBIT | 18.40% | 101.15% | 41.46% | -59.72% | -30.42% |
| EBITDA | 31.99% | 84.02% | 44.67% | -19.32% | -35.61% |
| EPS Basic | -105.61% | 304.17% | -311.54% | -116.67% | 196.40% |
| Normalized Basic EPS | -104.55% | 2,350.00% | -244.44% | -105.26% | 2,300.00% |
| EPS Diluted | -105.88% | 304.17% | -311.54% | -120.00% | 191.89% |
| Normalized Diluted EPS | -104.65% | 2,350.00% | -244.44% | -105.26% | 2,250.00% |
| Average Basic Shares Outstanding | 9.14% | 1.28% | -0.24% | -0.03% | -3.68% |
| Average Diluted Shares Outstanding | 6.79% | 2.02% | -0.24% | -0.03% | -1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |